Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brixton Biosciences in the transaction. Brixton Biosciences, a clinical stage life sciences company, announced it has raised $33...
This content is for Standard 1 Year members only. LoginJoin Now